好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Health Literacy in Older Adults with Normal Cognition and Mild Cognitive Impairment in the Alzheimer’s Disease Research Center cohort at the University of Alabama at Birmingham
Aging, Dementia, and Behavioral Neurology
P9 - Poster Session 9 (5:00 PM-6:00 PM)
12-014

Assess health literacy (HL) among cognitively normal (CN) older adults (>65years) and those with Mild Cognitive Impairment (MCI) by demographic factors in the UAB Alzheimer’s Disease Research Center (ADRC) clinical cohort.

Previous studies found that low HL in older adults might influence healthcare utilization, resulting in negative health outcomes further worsened by cognitive impairment.

Data was obtained from National Alzheimer’s Coordinating Center Uniform Data Set 3.0 and the Social and Structural Determinants Influencing Aging and Dementia battery - Calgary Charter for Health Literacy scale (CCHL) of UAB ADRC participants from 2020-2025. Bivariate analyses compared baseline demographic characteristics [sex, age, years of education (YOE)] and HL scores among CN adults (76, 59.38%) and participants with MCI (52, 40.63%) by race. Spearman’s rank correlation examined associations between YOE and HL scores overall and by race within clinical diagnosis groups.

Among the 128 participants, 94 (73.4%) were women, 85 (66.4%) self-identified as African American (AA), mean age was 68.1 (±7.1), mean YOE was 15.2 (±2.5), and mean CCHL was 9.5 (±2.7) indicating moderate HL. Compared to white, AA participants were more likely to have a clinical diagnosis of MCI (X= 13.0170, p= 0.0003), and fewer YOE (Z = 3.89, P= 0.0002). When ascertained by race and cognitive status, AAs were younger (p= 0.0021) and had fewer YOE in the MCI group (p=0.0005). However, there was no significant difference in HL scores by race or clinical diagnosis and no overall significant association between YOE and HL. A significant positive correlation between YOE and HL (p < 0.05) was identified among white CN participants.

Associations are varied between YOE and HL by race and clinical diagnosis. These differences may be driven by specific individual and context level factors such as care – seeking behaviors, disease perceptions, field of study and social support warranting further study.

Authors/Disclosures
Prithvi S. Gaur, MD, MBBS
PRESENTER
Dr. Gaur has nothing to disclose.
Rabia Saeed, MBBS Miss Saeed has nothing to disclose.
Giovanna Pilonieta, PhD, DMD, MPH (University of Alabama At Birmingham) The institution of Dr. Pilonieta has received research support from NIH. The institution of Dr. Pilonieta has received research support from NIH. The institution of Dr. Pilonieta has received research support from American Brain Foundation.
David Geldmacher, MD (UAB Department of Neurology) Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Geldmacher has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrownGreer. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Premier, Inc. Dr. Geldmacher has stock in Doximity. The institution of Dr. Geldmacher has received research support from Biogen. The institution of Dr. Geldmacher has received research support from Eisai. The institution of Dr. Geldmacher has received research support from Janssen. The institution of Dr. Geldmacher has received research support from National Institutes of Health. The institution of Dr. Geldmacher has received research support from Vaccinex. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a CME presenter with Medscape. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a CME presenter with Med Learning Group. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生.
Erik Roberson, MD, PhD (University of Alabama at Birmingham) Dr. Roberson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Roberson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society for Neuroscience. The institution of Dr. Roberson has received research support from NIH. The institution of Dr. Roberson has received research support from Alzheimer's Drug Discovery Foundation. The institution of Dr. Roberson has received research support from Bluefield Project. Dr. Roberson has received intellectual property interests from a discovery or technology relating to health care. Dr. Roberson has received publishing royalties from a publication relating to health care. Dr. Roberson has received personal compensation in the range of $10,000-$49,999 for serving as a Scientific Advisory Board with Kissick Family Foundation.